GlassScriptPhysician profile
Mohan P Philip
NPI 1124093471
$7,103.25
in general payments reported to CMS, 2019-2025
38 companies · $846 in 2025
The $846 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,243 · 2020: $292 · 2021: $662 · 2022: $471 · 2023: $1,709 · 2024: $881 · 2025: $846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,676 · Travel and Lodging: $1,586 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,675.87 |
| Travel and Lodging | $1,585.96 |
| Education | $173.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $1,506.12 | 2019 | |
| Inspire Medical Systems, INC. | $1,285.99 | 2023 | Inspire |
| Astrazeneca Pharmaceuticals LP | $877.62 | 2019-2025 | Tezspire, Fasenra |
| Glaxosmithkline, LLC. | $510.07 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Noah Medical Corporation | $377.92 | 2025 | Galaxy |
| Mylan Specialty L.P. | $247.43 | 2019-2024 | Yupelri |
| Medical Device Business Services, INC. | $228.15 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $217.00 | 2019-2024 | Ofev |
| Ethicon INC. | $162.55 | 2024-2025 | Monarch Platform |
| Baxter Healthcare | $161.28 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Harmony Biosciences LLC | $159.08 | 2023-2024 | Wakix |
| Actelion Pharmaceuticals US, INC. | $143.56 | 2024-2025 | Opsumit, Uptravi |
| Sunovion Pharmaceuticals INC. | $133.08 | 2019 | |
| Genzyme Corporation | $119.62 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $106.66 | 2019-2024 | Dupixent |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $90.29 | 2019-2025 | Prolastin-C Liquid |
| Sanofi-Aventis U.S. LLC | $84.99 | 2025 | |
| Insmed, INC. | $75.01 | 2021-2025 | Arikayce |
| Genentech USA, INC. | $71.79 | 2019-2021 | |
| Advanced Respiratory, INC | $71.01 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $49.34 | 2023-2024 | Keytruda |
| Viatris Specialty LLC | $43.42 | 2025 | Yupelri |
| Verona Pharma, INC. | $38.20 | 2025 | Ohtuvayre |
| United Therapeutics Corporation | $35.13 | 2024 | Tyvaso |
| Takeda Pharmaceuticals U.S.A., INC. | $32.47 | 2021 | |
| Janssen Pharmaceuticals, INC | $31.24 | 2021-2022 | |
| Amgen INC. | $30.76 | 2025 | Tezspire |
| Electromed, INC. | $27.48 | 2024 | Smartvest |
| Jazz Pharmaceuticals INC. | $27.15 | 2021 | |
| Fisher & Paykel Healthcare INC | $24.89 | 2021 | |
| Ceribell, INC. | $23.00 | 2025 | Pocket Eeg Device |
| Axsome Therapeutics, INC. | $18.00 | 2023 | Sunosi |
| Mallinckrodt Enterprises LLC | $17.52 | 2019 | |
| Inogen, INC. | $17.20 | 2025 | |
| Gilead Sciences, INC. | $16.83 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $15.34 | 2021 | |
| Philips North America LLC | $13.34 | 2022 | |
| Circassia INC. | $12.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohan Philip listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.